Cumberland Pharmaceuticals (CPIX) EPS (Weighted Average and Diluted): 2009-2025
Historic EPS (Weighted Average and Diluted) for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -$0.13.
- Cumberland Pharmaceuticals' EPS (Weighted Average and Diluted) fell 18.18% to -$0.13 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.24, marking a year-over-year increase of 68.83%. This contributed to the annual value of -$0.46 for FY2024, which is 4.55% down from last year.
- According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' EPS (Weighted Average and Diluted) is -$0.13, which was down 160.00% from -$0.05 recorded in Q2 2025.
- Cumberland Pharmaceuticals' 5-year EPS (Weighted Average and Diluted) high stood at $0.08 for Q2 2021, and its period low was -$0.44 during Q4 2023.
- In the last 3 years, Cumberland Pharmaceuticals' EPS (Weighted Average and Diluted) had a median value of -$0.08 in 2024 and averaged -$0.09.
- In the last 5 years, Cumberland Pharmaceuticals' EPS (Weighted Average and Diluted) spiked by 172.73% in 2021 and then slumped by 1,500.00% in 2024.
- Over the past 5 years, Cumberland Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at -$0.29 in 2021, then spiked by 41.38% to -$0.17 in 2022, then plummeted by 158.82% to -$0.44 in 2023, then spiked by 68.18% to -$0.14 in 2024, then declined by 18.18% to -$0.13 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.13 for Q3 2025, versus -$0.05 for Q2 2025 and $0.08 for Q1 2025.